Continuous daily dosing (CDD) of sunitinib (SU) in pts with advanced GIST: Updated efficacy, safety, PK and pharmacodynamic analysis

被引：3
|
作者：
George, S.
Blay, J. Y.
Casali, P. G.
Le Cesne, A.
DePrimo, S. E.
Harmon, C. S.
Law, C. N.
Tassell, V.
Baum, C. M.
Demetri, G. D.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Ist Nazl Tumori, I-20133 Milan, Italy
[4] Inst Gustave Roussy, Villejuif, France
[5] Pfizer Global Res & Dev, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.10554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10554
引用
收藏
页数：1
相关论文
共 28 条
  • [1] EFFICACY, SAFETY, PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF SUNITINIB (SU) ADMINSTERED ON A CONTINUOUS DAILY DOSING (CDD) SCHEDULE IN PATIENTS WITH ADVANCED GIST
    Blay, J.
    George, S.
    Casali, P. G.
    Le Cesne, A.
    Ray-Coquard, I.
    Harmon, C. S.
    Law, C. N. J.
    Tassell, V.
    Baum, C. M.
    Demetri, G. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 267 - 268
  • [2] Continuous daily dosing (CDD) of sunitinib malate (SU) compares favorably with intermittent dosing in pts with advanced GIST
    George, S.
    Blay, J. Y.
    Casali, P. G.
    Le Cesne, A.
    Morgan, J. A.
    Pokela, J.
    Quigley, M. T.
    Tassell, V.
    Baum, C. M.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Continuous daily dosing (CDD) study of sunitinib malate (SU) in patients (pts) with advanced GIST compares favorably with intermittent dosing
    Blay, J. Y.
    George, S.
    Casali, P. G.
    Le Cesne, A.
    Morgan, J. A.
    Pokela, J.
    Quigley, M. T.
    Tasse, V.
    Baum, C. M.
    Demetri, G. D.
    EJC SUPPLEMENTS, 2007, 5 (04): : 402 - 402
  • [4] Clinical benefit of continuous daily dosing of sunitinib in patients (pts) with advanced gastrointestinal stromal tumor (GIST)
    Blay, Jean-Yves
    George, Suzanne
    Casali, Paolo G.
    Le Cesne, Axel
    Morgan, Jeffrey A.
    Tyler, Angela
    Quigley, Michael T.
    Tassell, Vanessa
    Baum, Charles M.
    Demetri, George D.
    ANNALS OF ONCOLOGY, 2006, 17 : 163 - 163
  • [5] Efficacy, safety, pharmacokinetic and pharmacodynamic analysis of sunitinib adminstered on a continuous daily dosing schedule in patients with advanced gastrointestinal stromal tumor
    Blay, J.
    George, S.
    Casall, P.
    Le Cesne, A.
    Deprimo, S.
    Harmon, G.
    Law, C.
    Tassel, V
    Baum, C.
    Demetri, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 12 - 13
  • [6] Phase II study of sunitinib administered in a continuous daily dosing regimen in patients (pts) with advanced GIST.
    George, S.
    Casali, P. G.
    Blay, J.
    Le Cesne, A.
    Tyler, A. R.
    Quigley, M. T.
    Tassell, V.
    Baum, C. M.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 527S - 527S
  • [7] Clinical activity and tolerability of continuous daily dosing of sunitinib in patients with advanced GIST
    Blay, J.
    George, S.
    Casali, P.
    Le Cesne, A.
    Morgan, J.
    Pokela, J.
    Quigley, M.
    Tassell, V
    Baum, C.
    Demetri, G.
    ANNALS OF ONCOLOGY, 2007, 18 : VII24 - VII24
  • [8] Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial
    Keohan, M. L.
    Morgan, J. A.
    D'Adamo, D. R.
    Harmon, D.
    Butrynski, J. E.
    Wagner, A. J.
    Schwartz, G. K.
    Maki, R. G.
    Demetri, G. D.
    George, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] SUNITINIB (SU) IN A WORLDWIDE TREATMENT-USE TRIAL OF PATIENTS WITH GIST: UPDATED EFFICACY AND SAFETY ANALYSIS
    Reichardt, P.
    Kang, Y.
    Ruka, W.
    Seddon, B.
    Nieto, A.
    Breazna, A.
    Lechner, T.
    Demetri, G. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 267 - 267
  • [10] Continuous daily dosing of sunitinib in patients with advanced GIST: Initial results of a phase II study
    George, S.
    Casali, P.
    Blay, J.
    Le Cesne, A.
    Tyler, A.
    Quigley, M.
    Tassell, V
    Baum, C.
    Demetri, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 28 - 28
123